0000899243-22-034826.txt : 20221102 0000899243-22-034826.hdr.sgml : 20221102 20221102200026 ACCESSION NUMBER: 0000899243-22-034826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buckle Isabelle CENTRAL INDEX KEY: 0001823186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36415 FILM NUMBER: 221355782 MAIL ADDRESS: STREET 1: C/O QUOTIENT LIMITED, B1, BUSINESS PARK STREET 2: TERRE BONNE, ROUTE DE CRASSIER 13 CITY: EYSINS STATE: V8 ZIP: 1262 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quotient Ltd CENTRAL INDEX KEY: 0001596946 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 264719797 STATE OF INCORPORATION: Y9 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA BUSINESS PHONE: 41274832286 MAIL ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-31 0 0001596946 Quotient Ltd QTNT 0001823186 Buckle Isabelle C/O QUOTIENT LIMITED, BUSINESS PARK TERRE BONNE, ROUTE DE CRASSIER 13 EYSINS V8 1262 SWITZERLAND 1 0 0 0 Ordinary Shares 2022-10-31 4 M 0 6917 A 40652 D Ordinary Share Option (Right to Buy) 4.81 2030-09-01 Ordinary Shares 20790 20790 D Ordinary Share Option (Right to Buy) 4.81 2030-09-01 Ordinary Shares 2171 2171 D Ordinary Share Option (Right to Buy) 4.55 2030-10-31 Ordinary Shares 13611 13611 D Restricted Stock Units 2022-10-31 4 M 0 6917 0.00 D Ordinary Shares 6917 0 D Ordinary Share Option (Right to Buy) 2.53 2031-10-31 Ordinary Shares 24040 24040 D Restricted Stock Units 2022-10-31 4 A 0 70000 0.00 A Ordinary Shares 70000 70000 D Ordinary Share Option (Right to Buy) 0.13 2022-10-31 4 A 0 40000 0.00 A 2032-10-31 Ordinary Shares 40000 40000 D Restricted Stock Units convert into ordinary shares on a one-for-one basis. 6,930 options vested on September 1, 2022 and remain exercisable, and the remaining 6,930 options will vest on September 2, 2023. All 2,171 options have vested and remain exercisable. All 13,611 options have vested and remain exercisable. On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 27,668 have vested and have converted into ordinary shares. All 24,040 options have vested and remain exercisable. On October 31, 2022, the Reporting Person was granted 70,000 restricted stock units, vesting in four equal installments on January 31, 2023, April 30, 2023, July 31, 2023 and October 31, 2023. The options vest and become exercisable on October 31, 2023. /s/ Isabelle Buckle 2022-11-02